News|Articles|May 15, 2015
- Pharmaceutical Technology-05-15-2015
- Volume 2015 eBook
- Issue 2
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
Author(s)Joseph Brower, Eugene Wexler, PhD
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Advertisement
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Download
Articles in this issue
about 11 years ago
Sterilization Effects on Elastomers in Sterile Parenteral Drug Productsabout 11 years ago
Validating and Implementing a Rapid Sterility Testing Methodabout 11 years ago
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Footabout 11 years ago
Aging Facilities: Aseptic Manufacturing Faces the FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
BMS Bets on Flexible Capacity With $2.3B Texas Campus
4
Why the Orzeyful Approval Matters Beyond One Drug Class
5